Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DL5C1W
|
|||
| Drug Name |
Lifileucel
|
|||
| Synonyms |
LN-144
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1] | |
| Company |
Iovance Biotherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02360579) Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma (LN-144). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.